Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
09:00-09:15 | 09:00-09:15 |
Myocardial Amyloidosis: The Latest Progress in 2020 |
Yun Zhang | Qilu Hospital, Shandong University |
09:15-09:22 | 09:15-09:22 |
Discussion |
||
09:22-09:37 | 09:22-09:37 |
Adcances in the Prevention and Treatment of Tumor Associated Thrombus: Update in Chinese Guidelines |
Jun Ma | Harbin Institute of Hematology and Oncology |
09:37-09:44 | 09:37-09:44 |
Discussion |
||
09:44-09:59 | 09:44-09:59 |
Cardio-Oncology in China: Development and Future |
Yaling Han | General Hospital of Northern Theater Command |
09:59-10:06 | 09:59-10:06 |
Discussion |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
11:00-11:15 | 11:00-11:15 |
Oncological Cardiology: Full Protection |
Zeqi Zheng | The First Affiliated Hospital of Nanchang University |
11:15-11:22 | 11:15-11:22 |
Discussion |
||
11:22-11:37 | 11:22-11:37 |
Current Status of Cardiovascular Events Caused by Antitumor Therapy |
Zhiren Zhang | Harbin Medical University Cancer Hospital |
11:37-11:44 | 11:37-11:44 |
Discussion |
||
11:44-11:59 | 11:44-11:59 |
Early Screening and Prevention for Cardiotoxicity in Breast Cancer Therapy |
fei ma | |
11:59-12:06 | 11:59-12:06 |
Discussion |
||
12:06-12:21 | 12:06-12:21 |
Stratified Assessment and Screening of Cardiovascular Injury Caused by Anti-Tumor Therapy: Urgent Attention |
Yunlong Xia | The First Affiliated Hospital of Dalian Medical University |
12:21-12:30 | 12:21-12:30 |
Discussion |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
14:00-14:15 | 14:00-14:15 |
Interpretation of Management of Cardiac Disease in Cancer Patients throughout Oncological Treatment- 2020 ESMO Consensus Recommendations |
Mei Zhang | QiLu Hospital of ShangDong University |
14:15-14:22 | 14:15-14:22 |
Discussion |
||
14:22-14:37 | 14:22-14:37 |
Prevention of Cardiomyopathy caused by Antitumor Therapy |
Wei Meng | |
14:37-14:44 | 14:37-14:44 |
Discussion |
||
14:44-14:59 | 14:44-14:59 |
Cardiac Injury of Radiation Therapy |
Ligang Fang | |
14:59-15:06 | 14:59-15:06 |
Discussion |
||
15:06-15:21 | 15:06-15:21 |
Antitumor Therapy and Arrhythmia |
Tong Liu | Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University |
15:21-15:30 | 15:21-15:30 |
Discussion |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
16:00-16:15 | 16:00-16:15 |
Current Status of Echocardiographic Assessment of Antitumor Therapy-Associated Cardiac Injury |
Tiangang Zhu | Peking University People's Hospital |
16:15-16:22 | 16:15-16:22 |
Discussion |
||
16:22-16:37 | 16:22-16:37 |
Attempt and Experience of Cardio-Oncological MDT Outpatient Service |
Leilei Cheng | |
16:37-16:44 | 16:37-16:44 |
Discussion |
||
16:44-16:59 | 16:44-16:59 |
Immune Checkpoint Inhibitors and Myocarditis |
Qun Shao | |
16:59-17:06 | 16:59-17:06 |
Discussion |
||
17:06-17:21 | 17:06-17:21 |
Antitumor Therapy and Hypertension: Monitoring and Management of Blood Pressure in Cancer Survivors |
Ying Liu | The First Affiliated Hospital of Dalian Medical University |
17:21-17:30 | 17:21-17:30 |
Discussion |